Medicare Enrolled
Dr. Jeffrey Kim, M.D.
Pulmonary Disease · Emerson, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kim
Dr. Jeffrey Kim is a pulmonary disease specialist in Emerson, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kim performed 1,504 Medicare services across 753 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kim received a total of $7,936 from 37 pharmaceutical and/or device companies across 494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 49% volume in NJ
$7,936 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,504
Medicare services
Top 49% in NJ for pulmonary disease
753
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~79 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
904 | $107 | $365 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
132 | $94 | $326 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
90 | $125 | $550 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
76 | $146 | $665 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $71 | $250 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
54 | $135 | $448 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
41 | $104 | $342 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
30 | $185 | $911 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
24 | $66 | $229 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
21 | $8 | $9 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $69 | $237 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
16 | $6 | $44 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
15 | $7 | $41 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
15 | $5 | $202 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,936
Total received (2018-2024)
Avg $1,134/year across 7 years
Top 17% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
494
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,856 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,539
2023
$1,648
2022
$1,418
2021
$684
2020
$242
2019
$1,362
2018
$1,042
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$278
GENZYME CORPORATION
$207
GlaxoSmithKline, LLC.
$205
Insmed, Inc.
$139
Mylan Specialty L.P.
$99
SANOFI-AVENTIS U.S. LLC
$80
Actelion Pharmaceuticals US, Inc.
$80
Grifols USA, LLC
$52
Regeneron Healthcare Solutions, Inc.
$51
Philips North America LLC
$47
Harmony Biosciences Llc
$45
United Therapeutics Corporation
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
HARMONY BIOSCIENCES LLC
$31
Optinose US, Inc.
$31
Electromed, Inc.
$28
Baxter Healthcare
$18
Inspire Medical Systems, Inc.
$17
Amgen Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
Top 3 companies account for 44.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,524
AstraZeneca Pharmaceuticals LP
$1,060
Boehringer Ingelheim Pharmaceuticals, Inc.
$638
Philips Electronics North America Corporation
$621
Insmed, Inc.
$601
Mylan Specialty L.P.
$426
Grifols USA, LLC
$392
Electromed, Inc.
$353
GENZYME CORPORATION
$322
Sunovion Pharmaceuticals Inc.
$242
Regeneron Healthcare Solutions, Inc.
$188
Baxter Healthcare
$182
Actelion Pharmaceuticals US, Inc.
$145
Circassia Pharmaceuticals Inc
$136
United Therapeutics Corporation
$136
Covis Pharma GmBH
$105
SANOFI-AVENTIS U.S. LLC
$80
Takeda Pharmaceuticals U.S.A., Inc.
$62
Harmony Biosciences LLC
$61
IDORSIA PHARMACEUTICALS US INC
$57
Mallinckrodt Enterprises LLC
$57
PFIZER INC.
$56
Teva Pharmaceuticals USA, Inc.
$53
Jazz Pharmaceuticals Inc.
$49
Philips North America LLC
$47
Harmony Biosciences Llc
$45
Merck Sharp & Dohme LLC
$41
Merck Sharp & Dohme Corporation
$37
Inspire Medical Systems, Inc.
$36
Amgen Inc.
$33
HARMONY BIOSCIENCES LLC
$31
Optinose US, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$27
Tactile Systems Technology Inc
$18
Azurity Pharmaceuticals, Inc.
$15
Genentech USA, Inc.
$14
Resmed Corp
$13
Top 3 companies account for 40.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CINQAIR · DALIRESP · DUAKLIR PRESSAIR · DUPIXENT · Dymista · Esbriet · FARXIGA · FASENRA · Flexitouch Plus · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · Horizant · IMFINZI · INSPIRE · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · PANZYGA · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · VERQUVO · VYNDAQEL · WAKIX · Wellcentive Undiv · XYWAV · Xembify · Xhance · Xyrem · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
604
Per 100K population
63.3
County median income
$123,715
Nearest hospital
HACKENSACK MERIDIAN HEALTH PASCACK VALLEY MEDICAL
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kim is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kim experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kim performed 904 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $7,936 from 37 companies across 494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other pulmonary diseases in Emerson?
Dr. Kim's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Emerson
Browse pulmonary diseases in Emerson ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology